Evidence map›Paper›PMID 37329135›Full record

ArticleClinical and translational medicine2023

Trans-omic analyses identified novel prognostic biomarkers for colorectal cancer survival.

Chanjuan Liu, Furong Yan, Dongli Song, Yiming Zeng, Tiankui Qiao, Duojiao Wu, Yunfeng Cheng, Hao Chen

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chanjuan LiuCenter for Tumor Diagnosis & Therapy, Jinshan Hospital, Fudan University, Shanghai, China.
Furong YanCenter for Tumor Diagnosis & Therapy, Jinshan Hospital, Fudan University, Shanghai, China.ORCID 0000-0002-1916-3788
Dongli SongDepartment of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Yiming ZengCenter of Molecular Diagnosis and Therapy, The Second Hospital of Fujian Medical University, Quanzhou, Fujian, China.ORCID 0000-0001-5635-3006
Tiankui QiaoCenter for Tumor Diagnosis & Therapy, Jinshan Hospital, Fudan University, Shanghai, China.
Duojiao WuCenter for Tumor Diagnosis & Therapy, Jinshan Hospital, Fudan University, Shanghai, China.
Yunfeng ChengCenter for Tumor Diagnosis & Therapy, Jinshan Hospital, Fudan University, Shanghai, China.ORCID 0000-0002-9581-1134
Hao ChenDepartment of Thoracic Surgery, Zhongshan-Xuhui Hospital, Fudan University, Shanghai, China.ORCID 0000-0003-2786-9892

Funding

Key Subject Construction Program of Shanghai Health Administrative Authority ZK2019B30National Natural Science Foundation of China 82200043Quanzhou City Science & Technology Program of China 2018N008SScience and Technology Commission of Shanghai Municipality 21ZR1459000Shanghai Engineering Research Center of Tumor Multi-Target Gene Diagnosis 20DZ2254300
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Colorectal NeoplasmsBiomarkers, TumorHumansPrognosisBiomarkers, Tumor

Identifiers

PMID37329135
PMCPMC10276188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.